Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

A.I. Shown to Boost Cancer Clinical Trial Enrollment

Early results from a system using a supercomputer and artificial intelligence to match breast cancer patients to clinical trials shows faster screening and higher enrollment rates in these studies compared to manual methods. . . . → Read More: A.I. Shown to Boost Cancer Clinical Trial Enrollment

Peptide Hydrogel Boosts Cancer Immunotherapies

A team at Rice University in Houston developed an injectable gel material that in lab mice slows the release of cancer immunotherapy drugs, enhancing the treatments’ effectiveness and reducing the need for repeated doses. . . . → Read More: Peptide Hydrogel Boosts Cancer Immunotherapies

Company Formed to Develop Cancer Cell Therapies

The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells. . . . → Read More: Company Formed to Develop Cancer Cell Therapies

FDA Clears Consumer Genetic Breast Cancer Risk Tests

The Food and Drug Administration authorized the first direct-to-consumer tests of genetic risk for cancer, in this case 3 variations of genes associated with higher risk of breast and ovarian cancer. . . . → Read More: FDA Clears Consumer Genetic Breast Cancer Risk Tests

3-D Biomaterial Boosts Personal Cancer Immunotherapy

A Harvard University bioengineering lab developed an injectable material designed to load up with proteins from a patient’s own tumors to induce immune reactions that fight that person’s cancer. . . . → Read More: 3-D Biomaterial Boosts Personal Cancer Immunotherapy

Breathalyzer Biopsy Company Gains $15M in New Funds

A company in the U.K. developing a technology for early and precise diagnosis of lung and other cancers by analyzing exhaled breath is raising $15 million in new venture capital. . . . → Read More: Breathalyzer Biopsy Company Gains $15M in New Funds

Biotech Sponsoring Microbiome-Cancer Research

A biotechnology enterprise is starting research collaborations with cancer labs in the U.S. and Germany to study interactions of gut microbes on responses of individuals to cancer immunotherapies. . . . → Read More: Biotech Sponsoring Microbiome-Cancer Research

Precision Cancer Drug Shown Effective in Adults, Children

Results from 3 clinical trials show most cancer patients given an experimental drug that directly addresses a specific genetic mutation respond to the treatments, despite their cancers occurring in a variety of organs. . . . → Read More: Precision Cancer Drug Shown Effective in Adults, Children

Cancer Analytics Company Acquired in $1.9B Deal

The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells